Fair Value Distribution — percentile bands
81.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-1.0%/yr
±10.5% · revenue growth to justify current price
FCF-Based Reverse DCF
-7.7%/yr
±3.6% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockUnitedHealth Group Incorporated operates as a health care company in the United States and internationally.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
UNH's Q3 2025 filing reveals the worst earnings reset in the company's modern history. MCR hit 89.9% in Q3 (+470bps YoY), earnings from operations collapsed 50% to .3B, and EPS fell to .59 from .51. T...